NCT06413095: PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS |
|
|
| Completed | 1 | 13 | US | Pembrolizumab, Keytruda, MK-3475, MK-0482 + Pembrolizumab, MK-4830 + Pembrolizumab | Presage Biosciences, Merck Sharp & Dohme LLC | Head and Neck Squamous Cell Carcinoma, Soft Tissue Sarcoma | 06/23 | 06/23 | | |
